Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

989 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
JAK inhibitors are effective in a subset of patients with juvenile dermatomyositis: a monocentric retrospective study.
Le Voyer T, Gitiaux C, Authier FJ, Bodemer C, Melki I, Quartier P, Aeschlimann F, Isapof A, Herbeuval JP, Bondet V, Charuel JL, Frémond ML, Duffy D, Rodero MP, Bader-Meunier B. Le Voyer T, et al. Among authors: duffy d. Rheumatology (Oxford). 2021 Dec 1;60(12):5801-5808. doi: 10.1093/rheumatology/keab116. Rheumatology (Oxford). 2021. PMID: 33576769 Free article.
A child with severe juvenile dermatomyositis treated with ruxolitinib.
Aeschlimann FA, Frémond ML, Duffy D, Rice GI, Charuel JL, Bondet V, Saire E, Neven B, Bodemer C, Balu L, Gitiaux C, Crow YJ, Bader-Meunier B. Aeschlimann FA, et al. Among authors: duffy d. Brain. 2018 Nov 1;141(11):e80. doi: 10.1093/brain/awy255. Brain. 2018. PMID: 30335130 Free article. No abstract available.
Reverse-Transcriptase Inhibitors in the Aicardi–Goutières Syndrome.
Rice GI, Meyzer C, Bouazza N, Hully M, Boddaert N, Semeraro M, Zeef LAH, Rozenberg F, Bondet V, Duffy D, Llibre A, Baek J, Sambe MN, Henry E, Jolaine V, Barnerias C, Barth M, Belot A, Cances C, Debray FG, Doummar D, Frémond ML, Kitabayashi N, Lepelley A, Levrat V, Melki I, Meyer P, Nougues MC, Renaldo F, Rodero MP, Rodriguez D, Roubertie A, Seabra L, Uggenti C, Abdoul H, Treluyer JM, Desguerre I, Blanche S, Crow YJ. Rice GI, et al. Among authors: duffy d. N Engl J Med. 2018 Dec 6;379(23):2275-7. doi: 10.1056/NEJMc1810983. N Engl J Med. 2018. PMID: 30566312 Free article. No abstract available.
Type I interferon in patients with systemic autoimmune rheumatic disease is associated with haematological abnormalities and specific autoantibody profiles.
Reynolds JA, Briggs TA, Rice GI, Darmalinggam S, Bondet V, Bruce E, Khan M, Haque S, Chinoy H, Herrick AL, McCarthy EM, Zeef L, Hayes A, Duffy D, Parker B, Bruce IN. Reynolds JA, et al. Among authors: duffy d. Arthritis Res Ther. 2019 Jun 14;21(1):147. doi: 10.1186/s13075-019-1929-4. Arthritis Res Ther. 2019. PMID: 31200750 Free PMC article.
Circulating Interferon-α Measured With a Highly Sensitive Assay as a Biomarker for Juvenile Inflammatory Myositis Activity: Comment on the Article by Mathian et al.
Melki I, Devilliers H, Gitiaux C, Bondet V, Belot A, Bodemer C, Quartier P, Crow YJ, Duffy D, Rodero MP, Bader Meunier B. Melki I, et al. Among authors: duffy d. Arthritis Rheumatol. 2020 Jan;72(1):195-197. doi: 10.1002/art.41096. Epub 2019 Nov 23. Arthritis Rheumatol. 2020. PMID: 31487101 No abstract available.
Plasma Type I IFN Protein Concentrations in Human Tuberculosis.
Llibre A, Bilek N, Bondet V, Darboe F, Mbandi SK, Penn-Nicholson A, Hatherill M, Rozenberg F, Scriba TJ, Duffy D. Llibre A, et al. Among authors: duffy d. Front Cell Infect Microbiol. 2019 Aug 22;9:296. doi: 10.3389/fcimb.2019.00296. eCollection 2019. Front Cell Infect Microbiol. 2019. PMID: 31508378 Free PMC article.
Inhibition of IFNα secretion in cells from patients with juvenile dermatomyositis under TBK1 inhibitor treatment revealed by single-molecular assay technology.
Gitiaux C, Bondet V, Bekaddour N, Nusbaum P, Hubas A, Melki I, Bodemer C, Quartier P, Desguerre I, Crow YJ, Herbeuval JP, Duffy D, Bader Meunier B, Rodero MP. Gitiaux C, et al. Among authors: duffy d. Rheumatology (Oxford). 2020 May 1;59(5):1171-1174. doi: 10.1093/rheumatology/kez508. Rheumatology (Oxford). 2020. PMID: 31665500 Free article. No abstract available.
Use of ruxolitinib in COPA syndrome manifesting as life-threatening alveolar haemorrhage.
Frémond ML, Legendre M, Fayon M, Clement A, Filhol-Blin E, Richard N, Berdah L, Roullaud S, Rice GI, Bondet V, Duffy D, Sileo C, Ducou le Pointe H, Begueret H, Coulomb A, Neven B, Amselem S, Crow Y, Nathan N. Frémond ML, et al. Among authors: duffy d. Thorax. 2020 Jan;75(1):92-95. doi: 10.1136/thoraxjnl-2019-213892. Epub 2019 Oct 30. Thorax. 2020. PMID: 31666386
989 results